EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial

Sera Lortye iD, Joanne P Will, Loes A Marquenie, Nick M Lommerse, Nathalie Faber, Anna E Goudriaan, Arnoud Arntz, Marleen M de Waal

Addiction · 2025-11 · 120 (11) · 2231-2244

DOI: 10.1111/add.70097 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Addiction, online erschienen am 29.05.2025. Verfasst von Sera Lortye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Arkin Mental Health Care, Jellinek, Amsterdam Institute for Addiction Research, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Eye Movement Desensitization Reprocessing, Substance-Related Disorders, Implosive Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes-en Zenuwziekten.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Post‐traumatic stress disorder (PTSD) and substance use disorder (SUD) are highly co‐occurring and evidence for the optimal ways of treating PTSD in SUD patients is mixed. Our aim was to compare three different PTSD treatments, each added simultaneously to SUD treatment, with SUD treatment alone in patients with co‐occurring SUD‐PTSD. These PTSD treatments were: Prolonged Exposure (PE), Eye Movement Desensitization and Reprocessing (EMDR) and Imagery Rescripting (ImRs).

Design

A single‐blind 4‐arm randomized controlled trial with follow‐up at 3 months.

Setting

Two addiction treatment centers in the Netherlands, providing intra‐ and extramural care.

Participants

209 patients with SUD and co‐morbid PTSD were included [mean age 37.5 (standard deviation, SD = 11.99), female sex = 46.4%, mean Clinically Administered PTSD Scale (CAPS) score = 37.35 (SD = 9.28)].

Interventions

Participants were randomized to either simultaneous SUD + PE ( n = 53), SUD + EMDR ( n = 50), SUD + ImRs ( n = 55) or to SUD treatment only ( n = 51), with the active PTSD treatments consisting of 12 sessions each within 3 months. Standard protocols were used.

Measurements

The primary outcome was clinician‐administered PTSD symptom severity as measured by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (CAPS‐5) at 3 month follow‐up. Secondary outcomes included loss of PTSD diagnosis, full remission of PSTD and SUD‐severity, also recorded at 3 months.

Findings

Compared with SUD only, the mean differences in CAPS‐5 score were B = −5.41 [95% confidence interval (CI) = 10.88, 0.05, P = 0.052] for SUD + PE, B = −7.97 (95% CI = −13.57, −2.37, P = 0.006) for SUD + EMDR and B = −10.03 (95% CI = −15.29, −4.77, P < 0.001) for SUD + ImRs. When adjusted for baseline covariates, mean differences were B = −5.81 (95% CI = −11.48, −0.15, P = 0.044) for SUD + PE, B = ‐8.85 (95% CI = −14.60, −3.10, P = 0.003) for SUD + EMDR and B = ‐10.75 (95% CI = −15.94, −5.56, P =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticEye Movement Desensitization ReprocessingSubstance-Related DisordersImplosive TherapyImagery, PsychotherapyHumansFemaleMaleAdultTreatment OutcomeSingle-Blind MethodMiddle AgedNetherlandsCombined Modality Therapy

Stichwörter der Autor:innen

eye movement desensitization and reprocessing (EMDR)imagery rescripting (ImRs)post‐traumatic stress disorder (PTSD)prolonged exposure (PE)substance use disorder (SUD)treatment effectiveness

Autor:innen und Institutionen

  • Arkin Mental Health Care, Jellinek, Amsterdam Institute for Addiction Research, Amsterdam, the Netherlands.
  • Department of Research, Arkin Mental Health Care, Amsterdam, the Netherlands.
  • Department of Psychiatry, University Medical Center (UMC) -University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Department of Clinical Psychology, University of Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Sera Lortye

Förderung

  • Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes-en Zenuwziekten

Zitieren

APA

Lortye, S., Will, J. P., Marquenie, L. A., Lommerse, N. M., Faber, N., Goudriaan, A. E., Arntz, A., & de Waal, M. M. (2025). Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial. Addiction, 120(11), 2231-2244. https://doi.org/10.1111/add.70097

Vancouver

Lortye S, Will JP, Marquenie LA, Lommerse NM, Faber N, Goudriaan AE, et al. Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial. Addiction. 2025;120(11):2231-2244. doi:10.1111/add.70097

BibTeX
@article{Lortye2025,
  author = {Lortye, Sera and Will, Joanne P and Marquenie, Loes A and Lommerse, Nick M and Faber, Nathalie and Goudriaan, Anna E and Arntz, Arnoud and de Waal, Marleen M},
  title = {Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial},
  journal = {Addiction},
  year = {2025},
  volume = {120},
  number = {11},
  pages = {2231--2244},
  doi = {10.1111/add.70097}
}
Kostenlos starten →